No Data
No Data
Express News | Pulmatrix Enters Cross License Agreement With MannKind To Use Cricket Inhalation Device For Delivery Of PUR3100 And Other Dry Powder Formulations For Neurological Diseases
Express News | Pulmatrix Inc - as Part of Transaction, MannKind Will Assume Lease of Bedford, Mass., R&D Facility
Express News | Pulmatrix Inc - Assumption of Our Lease and Laboratory by MannKind Helps Extend Our Cash Runway Further Into 2026
Express News | Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation
MannKind to Establish Boston-Area Research & Development Foothold and Expand Portfolio of Dry Powder Inhalation Technology in Transaction With Pulmatrix
Express News | Pulmatrix Files For Mixed Shelf Of Upto $95M
No Data